Patent · US Active

Methods to improve cell therapy

US12090173B2 · kind B2 · utility

0Cited by
3References
15Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 10, 2022
Grant dateSep 17, 2024
Priority date
Expiry dateNov 10, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/724
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treatment are provided herein, including administration of a population cells modified to enforce expression of an E-selectin and/or an L-selectin ligand, the modified cell population having a cell viability of at least 70% after a treatment to enforce such expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.